What is a stock summary page? Click here for an overview.
Business Description
Athens Medical Centre SA
ISIN : GRS147233001
Compare
Compare
Traded in other countries / regions
IATR.GreeceACS.Germany0ONM.UK IPO Date
1991-08-29Description
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | 3.96 | |||||
| Interest Coverage | 1.87 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.12 | |||||
| Beneish M-Score | -2.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.3 | |||||
| 3-Year EBITDA Growth Rate | 20.2 | |||||
| 3-Year EPS without NRI Growth Rate | 34.8 | |||||
| 3-Year FCF Growth Rate | -51.3 | |||||
| 3-Year Book Growth Rate | 7.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.02 | |||||
| 9-Day RSI | 58.99 | |||||
| 14-Day RSI | 57.05 | |||||
| 3-1 Month Momentum % | 32.89 | |||||
| 6-1 Month Momentum % | 26.98 | |||||
| 12-1 Month Momentum % | 11.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.91 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 12.29 | |||||
| Days Sales Outstanding | 177.42 | |||||
| Days Payable | 166.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.01 | |||||
| Dividend Payout Ratio | 0.32 | |||||
| Forward Dividend Yield % | 1.01 | |||||
| 5-Year Yield-on-Cost % | 1.03 | |||||
| Shareholder Yield % | -3.86 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.17 | |||||
| Operating Margin % | 7.62 | |||||
| Net Margin % | 2.88 | |||||
| FCF Margin % | 9.42 | |||||
| ROE % | 6.94 | |||||
| ROA % | 1.61 | |||||
| ROIC % | 3.92 | |||||
| 3-Year ROIIC % | -22.17 | |||||
| ROC (Joel Greenblatt) % | 8.13 | |||||
| ROCE % | 8.06 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.56 | |||||
| PE Ratio without NRI | 21.35 | |||||
| Shiller PE Ratio | 67.56 | |||||
| Price-to-Owner-Earnings | 80 | |||||
| PEG Ratio | 2.22 | |||||
| PS Ratio | 0.63 | |||||
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.56 | |||||
| Price-to-Free-Cash-Flow | 6.83 | |||||
| Price-to-Operating-Cash-Flow | 3.24 | |||||
| EV-to-EBIT | 13.22 | |||||
| EV-to-EBITDA | 7.75 | |||||
| EV-to-Revenue | 1.11 | |||||
| EV-to-FCF | 11.66 | |||||
| Price-to-GF-Value | 0.89 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.11 | |||||
| Price-to-Graham-Number | 1.22 | |||||
| Earnings Yield (Greenblatt) % | 7.56 | |||||
| FCF Yield % | 14.59 | |||||
| Forward Rate of Return (Yacktman) % | 14.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Athens Medical Centre SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 266.749 | ||
| EPS (TTM) (€) | 0.088 | ||
| Beta | 0.8 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.46 | ||
| Volatility % | 32.48 | ||
| 14-Day RSI | 57.05 | ||
| 14-Day ATR (€) | 0.072472 | ||
| 20-Day SMA (€) | 1.94225 | ||
| 12-1 Month Momentum % | 11.42 | ||
| 52-Week Range (€) | 1.44 - 2.12 | ||
| Shares Outstanding (Mil) | 86.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Athens Medical Centre SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Athens Medical Centre SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Athens Medical Centre SA Frequently Asked Questions
What is Athens Medical Centre SA(ATH:IATR)'s stock price today?
The current price of ATH:IATR is €1.99. The 52 week high of ATH:IATR is €2.12 and 52 week low is €1.44.
When is next earnings date of Athens Medical Centre SA(ATH:IATR)?
The next earnings date of Athens Medical Centre SA(ATH:IATR) is .
Does Athens Medical Centre SA(ATH:IATR) pay dividends? If so, how much?
The Dividend Yield % of Athens Medical Centre SA(ATH:IATR) is 1.01% (As of Today), Highest Dividend Payout Ratio of Athens Medical Centre SA(ATH:IATR) was 0.85. The lowest was 0.31. And the median was 0.58. The Forward Dividend Yield % of Athens Medical Centre SA(ATH:IATR) is 1.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers